PDD Q4 2025 Earnings EPS Misses Estimates by Wide Margin Stock Declines InMed Pharmaceuticals Q3 2025 Earnings Continued Losses as Stock Declines TransAct Technologies TACT Q1 2026 Earnings Surprise Profitability as EPS Beats Estimates by Wide Margin VRDN Q1 2026 Earnings NarrowerthanExpected Loss as Viridian Advances Clinical Pipeline CIFR Q1 2026 Earnings EPS Misses Estimates Stock Rises Amid Uncertainty CIG Q1 2026 Earnings EPS Beats Estimates by 1247 Shares Edge Lower